References
Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169–180. https://doi.org/10.1056/NEJMra1401483
Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127. https://doi.org/10.1002/ana.1032
Cerqueira JJ, Compston DAS, Geraldes R et al (2018) Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry 89:844–850. https://doi.org/10.1136/jnnp-2017-317509
Sati P, Oh J, Constable RT et al (2016) The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 12:714–722. https://doi.org/10.1038/nrneurol.2016.166
Tranfa M, Pontillo G, Petracca M et al (2022) Quantitative MRI in multiple sclerosis: from theory to application. AJNR Am J Neuroradiol 43(12):1688–1695. https://doi.org/10.3174/ajnr.A7536
Al-Louzi O, Letchuman V, Manukyan S et al (2022) Central vein sign profile of newly developing lesions in multiple sclerosis: a 3-year longitudinal study. Neurol Neuroimmunol Neuroinflamm 9(2):e1120. https://doi.org/10.1212/NXI.0000000000001120
Maggi P, Absinta M, Grammatico M et al (2018) Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol 83:283–294. https://doi.org/10.1002/ana.25146
Sinnecker T, Clarke MA, Meier D et al (2019) Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 76:1446–1456. https://doi.org/10.1001/jamaneurol.2019.2478
Tranfa M, Tortora M, Pontillo G et al (2022) The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease. Eur Radiol 32:3846–3854. https://doi.org/10.1007/s00330-021-08487-4
Castellaro M, Tamanti A, Pisani AI et al (2020) The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis. Diagnostics 10:1025. https://doi.org/10.3390/diagnostics10121025
Dal-Bianco A, Grabner G, Kronnerwetter C et al (2021) Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. Brain 144:833–847. https://doi.org/10.1093/brain/awaa436
Frischer JM, Weigand SD, Guo Y et al (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78(5):710–721. https://doi.org/10.1002/ana.24497
Maggi P, Sati P, Nair G et al (2020) Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study. Ann Neurol 88:1034–1042. https://doi.org/10.1002/ana.25877
Bevan RJ, Evans R, Griffiths L et al (2018) Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Ann Neurol 84:829–842. https://doi.org/10.1002/ana.25365
Filippi M, Preziosa P, Arnold DL et al (2023) Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective. J Neurol 270:1286–1299. https://doi.org/10.1007/s00415-022-11488-y
La Rosa F, Wynen M, Al-Louzi O et al (2022) Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: emerging machine learning techniques and future avenues. Neuroimage Clin 36:103205. https://doi.org/10.1016/j.nicl.2022.103205
Nabizadeh F, Masrouri S, Ramezannezhad E et al (2022) Artificial intelligence in the diagnosis of multiple sclerosis: a systematic review. Mult Scler Relat Disord 59:103673. https://doi.org/10.1016/j.msard.2022.103673
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Sirio Cocozza.
Conflict of interest
S.C. received speaker fees from Sanofi and Amicus Therapeutics and a Research Grant from FISM (Fondazione Italiana Sclerosi Multipla) and Telethon.
The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
n.a.
Informed consent
n.a.
Ethical approval
n.a.
Study subjects or cohorts overlap
n.a.
Methodology
• Commentary
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pontillo, G., Cocozza, S. The rising role of magnetic resonance imaging biomarkers in diagnosing multiple sclerosis. Eur Radiol 33, 8043–8045 (2023). https://doi.org/10.1007/s00330-023-09738-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09738-2